0001415889-23-011118.txt : 20230714
0001415889-23-011118.hdr.sgml : 20230714
20230714161719
ACCESSION NUMBER: 0001415889-23-011118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230712
FILED AS OF DATE: 20230714
DATE AS OF CHANGE: 20230714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferra Joseph J Jr
CENTRAL INDEX KEY: 0001733790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40523
FILM NUMBER: 231089331
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevation Oncology, Inc.
CENTRAL INDEX KEY: 0001783032
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 841771427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6380
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
FORMER COMPANY:
FORMER CONFORMED NAME: 14ner Oncology, Inc.
DATE OF NAME CHANGE: 20190719
4
1
form4-07142023_080716.xml
X0407
4
2023-07-12
0001783032
Elevation Oncology, Inc.
ELEV
0001733790
Ferra Joseph J Jr
C/O ELEVATION ONCOLOGY, INC.
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
false
true
false
false
CHIEF EXECUTIVE OFFICER
0
Stock Option (Right to Buy)
1.51
2023-07-12
4
A
0
35000
0
A
2033-07-11
Common Stock
35000
35000
D
The stock option vests as to 25% of the total shares on July 12, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
/s/ Robert Yang, Attorney-in-Fact
2023-07-14